Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Moderate Aplastic Anemia Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01328587
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:04.569289+00:00
Published At
2019-04-23T00:00:00+00:00
Record Updated At
2026-04-23
Results Posted At
2019-04-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Moderate Aplastic Anemia", "Unilineage Bone Marrow Failure Disorders"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-23"
protocolSection.identificationModule.nctId
"NCT01328587"
protocolSection.identificationModule.officialTitle
"A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Moderate Aplastic Anemia Patients"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-04-23"

Study condition terms

  • Moderate Aplastic Anemia (protocolSection.conditionsModule.conditions)
  • Unilineage Bone Marrow Failure Disorders (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.